Sheng Jiang

25PUBLICATIONS
18CO-AUTHORS
Molecular targetsClinical pharmacology and therapeuticsBiologically active moleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 22, 2026
Discovery of Novel Dual Small-Molecule Inhibitors Targeting SHP2 and NAMPT for Overcoming Resistance to Allosteric SHP2 Inhibition.

|Jan 28, 2026
Seeking Equality from an Asymmetric System: The Convergent Total Synthesis of Prostacyclin Drug (±)-Beraprost Sodium.

Xinyu Zhu, Zhihao Qi, Jingfan Pan

|Jan 17, 2026
Dual PARP/NAMPT Inhibitors for BRCA Wild-Type Triple-Negative Breast Cancer: Disrupting Homologous Recombination Repair and Activating Antitumor Immunity.

Kaizhen Wang, Dexiang Wang, Jun Tong

|Jul 30, 2025
Discovery of a Novel Potent and Orally Efficacious PROTAC Degrader of HPK1 for Tumor Immunotherapy.

Jun Tong, Kaizhen Wang, Chenyi Liu

|Jul 09, 2025
Traceless Nitro Group Directing Strategy: Modular Syntheses of the Scaffolds of Polycyclic Alkaloids.

Qing Li, Yuting Zhao, Xinyu Zhu

|Feb 27, 2025
Discovery, Synthesis, and Activity Evaluation of Novel Small-Molecule Inhibitors Targeting VISTA for Cancer Immunotherapy.

Zhihao Qi, Yao Cheng, Kaizhen Wang

Pageof 5

Frequent Collaborators

8 joint publications

Xiangyu Zhang

7 joint publications

Tianyu Wang

7 joint publications

Kuojun Zhang

2 joint publications

Zheng Li